Health Catalyst Stock News

Health Catalyst Inc (HCAT) shares closed today at 0.1% above its 52 week low of $33.92, giving the company a market cap of $1B. The stock is currently down 14.3% year-to-date, down 24.0% over the past 12 months, and down 13.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 28.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 90.0% The company's stock price performance over the past 12 months beats the peer average by -1.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Health Catalyst Inc (HCAT) shares closed today at 0.1% above its 52 week low of $33.92, giving the company a market cap of $1B. The stock is currently down 14.3% year-to-date, down 21.4% over the past 12 months, and down 13.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 28.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 106.6% The company's stock price performance over the past 12 months beats the peer average by -8.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Health Catalyst Inc (HCAT) shares closed 0.8% lower than its previous 52 week low, giving the company a market cap of $2B. The stock is currently down 2.3% year-to-date, down 9.1% over the past 12 months, and down 1.2% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 3.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -6.5% The company's stock price performance over the past 12 months beats the peer average by -55.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SALT LAKE CITY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organization

SALT LAKE CITY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,

Health Catalyst (NASDAQ:HCAT) had its target price lowered by Citigroup from $68.00 to $55.00 in a research report released on Monday morning, Price Targets.com reports. The brokerage currently has a buy rating on the stock. Other equities research analysts have also recently issued reports about the company. Zacks Investment Research cut Health Catalyst from a []

Health Catalyst (NASDAQ:HCAT) had its target price dropped by Citigroup from $68.00 to $55.00 in a note issued to investors on Monday, Analyst Price Targets reports. The firm presently has a buy rating on the stock. Citigroups price target suggests a potential upside of 43.15% from the companys current price. Several other equities analysts have [] The post Health Catalyst (NASDAQ:HCAT) Price Target Cut to $55.00 appeared first on ETF Daily News .

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have been assigned a consensus rating of Buy from the twelve brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, nine have given a buy recommendation and one has issued a []

Health Catalyst Inc. (NASDAQ:HCAT) price on Friday, December 10, fall -2.11% below its previous days close as a downside momentum from buyers pushed the stocks value to $37.12. A look at the stocks price movement, the close in the last trading session was $37.92, moving within a range at $36.89 and $38.535. The beta value What Can Health Catalyst Inc. (NASDAQ: HCAT) Expect In 2021? Read More »

Snap (NYSE:SNAP) and Health Catalyst (NASDAQ:HCAT) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends. Risk & Volatility Snap has a beta of 1.09, indicating that its stock price is []

Health Catalyst, Inc. (NASDAQ:HCAT)s share price hit a new 52-week low during trading on Friday . The stock traded as low as $37.14 and last traded at $37.14, with a volume of 3573 shares changing hands. The stock had previously closed at $37.92. A number of analysts have recently weighed in on the stock. Jefferies []

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Daniel D. Burton sold 21,972 shares of the stock in a transaction that occurred on Monday, December 6th. The shares were sold at an average price of $40.06, for a total transaction of $880,198.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is []

Related Stocks: HCAT ,

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Daniel D. Burton sold 21,972 shares of Health Catalyst stock in a transaction that occurred on Monday, December 6th. The stock was sold at an average price of $40.06, for a total transaction of $880,198.32. The transaction was disclosed in a legal filing with the SEC, which is available through []

Health Catalyst, Inc. (NASDAQ:HCAT) Equities researchers at Jefferies Financial Group issued their FY2021 earnings estimates for shares of Health Catalyst in a research report issued on Wednesday, December 1st. Jefferies Financial Group analyst G. Santangelo expects that the company will post earnings per share of ($1.95) for the year. Jefferies Financial Group currently has []